Christina Haeyoung Yeon, M.D., M.H.M.

877-998-7546
Meet Medical Oncologist/Hematologist Christina H. Yeon, M.D.
Play
Medical Oncologist
5 (172 RATINGS)
Clinical Expertise
Breast Cancer
Research Area
Breast Cancer
Appointments
Regional Director For San Gabriel Valley
Associate Clinical Professor, Department Of Medical Oncology & Therapeutics Research
Clinical Teams
Breast Cancer
Medical Oncology & Therapeutics Research
Christina Haeyoung Yeon, M.D., M.H.M., immigrated to the U.S. from Seoul, Korea, at age 5 and grew up in Riverside, California. She completed the majority of her higher education at the University of California Los Angeles, including a bachelor’s degree in biochemistry, a medical doctorate, an internal medicine residency and a combined medical oncology/hematology fellowship.
 
Dr. Yeon has practiced medical oncology/hematology in Pasadena, California, since 2004. She has extensive experience in the diagnosis and treatment of all adult malignancies, as well as benign/malignant hematologic disorders, with a special interest in breast oncology.
 
She has been a key member of City of Hope’s South Pasadena team since joining the practice in 2011. After serving as site lead physician for the South Pasadena clinic starting in 2014, she then became the regional director for the clinical network sites in the San Gabriel Valley in 2018. There are currently six clinical network sites in this region. In her leadership role, she works closely with operations colleagues to oversee and optimize all aspects of care delivery across multiple medical specialties.
 
In addition to her clinical and leadership duties, Dr. Yeon serves on multiple committees at City of Hope. These include the compliance, credentials, retirement, benefits and physician well-being committees. She has also been elected by her peers to the medical executive committee and the medical group board of directors.
 
Dr. Yeon has lived locally within the community since 2005. She lives in La Crescenta, California, with her husband and three children.
Location
Education & Experience
Board Certifications

  • 2015, American Board of Internal Medicine — Subspecialty of Hematology

  • 2014, American Board of Internal Medicine — Subspecialty of Medical Oncology

  • 2001, American Board of Internal Medicine

Degrees

  • 2022, Masters of Healthcare Management (M.H.M), Eller College of Management, University of Arizona, Tucson, AZ

  • 1998, M.D., UCLA, Los Angeles, CA

  • 1994, B.S., biochemistry, Summa Cum Laude, UCLA, Los Angeles, CA

Fellowship

  • 2001-2004, Fellow, Hematology/Oncology, UCLA, Los Angeles, CA

Residency

  • 1999-2001, Resident, Internal Medicine, UCLA, Los Angeles, CA

Internship

  • 1998-1999, Intern, Internal Medicine, UCLA, Los Angeles, CA

Professional Experience

  • 2019-present, Associate Clinical Professor, Department
    of Medical Oncology & Therapeutics Research, City of Hope, South Pasadena and Duarte, CA

  • 2018-present, Regional Director for San Gabriel Valley, City of Hope, South Pasadena, CA

  • 2011-2019, Assistant Clinical Professor, Department
    of Medical Oncology & Therapeutics Research, City of Hope, South Pasadena, CA

  • 2004-2011, Physician, Wilshire Oncology Medical Group Inc., Pasadena, CA

Awards & Memberships
Memberships

  • American Society of Clinical Oncology

Publications

  • Lavasani SM, Somlo G, Yost SE, Frankel PH, Ruel C, Cui Y, Murga M, Tang A, Martinez N, Kruper L, Tumyan L, Schmolze D, Yeon C, Yuan Y, Waisman JR, Mortimer J. Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancer. Cancer. 2022 Dec 14. DOI: 10.1002/cncr.34589. 

  • Bosserman LD, Cianfrocca M, Yuh B, Yeon C, Chen H, Sentovich S, Polverini A, Zachariah F, Deaville D, Lee A, Sedrak M, King E, Gray S, Morse D, Glaser S, Bhatt G, Adeimy C, Tan T, Chao J, Nam A, Paz I, Kruper L, Rao P, Sokolov K, Kulkarni P, Salgia R, Yamzon J, Johnson D. Integrating academic and community cancer care and research through multidisciplinary oncology pathways for value-based care: a review and the City of Hope experience. J Clin Med. 2021 Jan 7;10(2):188. DOI: 10.3390/jcm10020188.

  • Yuan Y, Lee JS, Yost SE, Li SM, Frankel PH, Ruel C, Schmolze D, Robinson K, Tang A, Martinez N, Stewart D, Waisman J, Kruper L, Jones V, Menicucci A, Uygun S, Yoder E, van der Baan B, Yim JH, Yeon C, Somlo G, Mortimer J. Phase II trial of neoadjuvant carboplatin and nab-paclitaxel in patients with triple-negative breast cancer. Oncologist. 2020 Oct 24. DOI: 10.1002/onco.13574.

  • Mortimer JE, Kruper L, Cianfrocca M, Lavasani S, Liu S, Tank-Patel N, Sedrak M, Smith W, Stewart D, Waisman J, Yeon C, Wang T, Yuan Y.  Use of HER2-directed therapy in metastatic breast cancer and how community physicians collaborate to improve care. J Clin Med. 2020 June 24;9(6):1984. DOI: 10.3390/jcm9061984.

  • Liu J, Gutierrez E, Tiwari A, Padam S, Li D, Dale W, Pal SK, Stewart D, Subbiah S, Bosserman LD, Presant C, Phillips T, Yap K, Hill A, Bhatt G, Yeon C, Cianfrocca M, Yuan Y, Mortimer J, Sedrak MS. Strategies to improve participation of older adults in cancer research. J Clin Med. 2020 May 22; 9(5): 1571. DOI: 10.3390/jcm9051571.

  • Hurria A, Soto Perez de Celis E, Blanchard S, Burhenn P, Yeon C, Yuan Y, Li D, Katheria V, Waisman JR, Luu TH, Somlo G, Noonan AM, Lee T, Sudan N, Chung S, Rotter A, Arsenyan A, Levi A, Mortimer JE.  A phase II trial of older adults with metastatic breast cancer receiving nab-paclitaxel:  melding the fields of geriatrics and oncology. Clin Breast Cancer. 2019 Apr; 19(2): 89-96. DOI: 10.1016/j.clbc.2018.10.002.

  • Ashing KT, Cho D, Lai L, Yeung S, Young L, Yeon C, Fong Y.  Exploring characteristics, predictors, and consequences of fear of cancer recurrence among Asian-American breast cancer survivors.  Psycho-Oncology. 2017 Dec; 26(12): 2253-2260. DOI: 10.1002/pon.4350.

  • Chung V, Frankel P, Lim D, Yeon C, Leong L, Chao J, Ruel N, Luevanos E, Koehler S, Chung S, Lau SC, Fakih MG.  Phase Ib trial of mFOLFOX6 and everolimus (NSC-733504) in patients with metastatic gastroesophageal adenocarcinoma. Oncology 2016 Apr 20, 90(6): 307-312. DOI: 10.1159/000445297.

  • Lai L, Woo D, Chapman Y, Sudan N, Yeon CH, Trisal V and Waisman JR.  Mismatch of available cancer therapeutic trials to patient populations in community practices [abstract]. In:  Proc Am Soc Clin Oncol; 2014. Abstract 84.
  • Chung V, Frankel P, Lim D, Chao J, Yeon CH, Leong L, Kim J, Luevanos E, Rose C and Fakih M.  A phase 1b trial of mFOLFOX6 and everolimus (NSC-733504) in patients with metastatic gastroesophageal adenocarcinoma (NCT01231399) [abstract]. In: Proc Am Soc Clin Oncol; 2014.  Abstract e15007.
 
Ratings & Reviews
Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with 5 stars being the highest.
Ratings
5.0
Provider explain in way you understand
5.0
Provider listen carefully to you
5.0
Know important info medical history
5.0
Show respect for what you say
5.0
Spend enough time with you
5.0
Rate provider 0-10
5.0
Recommend this provider office
Reviews
01/21/23
Dr. Yeon is excellent!!! - Verified patient
12/31/22
Dr. Yeon is the best! - Verified patient
12/15/22
Dr. Yeon is the best - Verified patient
11/14/22
Everything I do or interact with City Of Hope is always top notch - Verified patient
10/30/22
Dr. Yeon Is very thorough, knowledgeable and to the point. She made understand the result of my biopsy like no other. She even made a diagram about my treatment plan. Thank you for people like you . - Verified patient